Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RM88 is a natural compound formula developed to reduce blood alcohol concentration (BAC) following alcohol intake. A controlled case series study demonstrated that RM88 significantly lowered BAC in subjects who consumed beer, wine, or spirits, with a mean reduction of 50.9% compared to control. RM88 was effective in rapidly reducing BAC to below legal limits within minutes, and efficacy was consistent across gender and age groups. The specific components and precise mechanism of action were not disclosed, but it is classified as a herbal or natural product with purported activity in alcohol metabolism enhancement or absorption mitigation[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RM88.